Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
17.55
-0.21 (-1.18%)
At close: Mar 5, 2026, 4:00 PM EST
17.56
+0.01 (0.06%)
After-hours: Mar 5, 2026, 7:54 PM EST
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$1,733,896
Market Cap
1.75B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Vericel | 357 |
| Zymeworks | 263 |
| Relay Therapeutics | 192 |
| Olema Pharmaceuticals | 122 |
| Pharvaris | 118 |
| Enliven Therapeutics | 65 |
| Trevi Therapeutics | 34 |
DFTX News
- 7 days ago - Definium Therapeutics, Inc. (DFTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates - Business Wire
- 9 days ago - Definium Therapeutics to Participate at Upcoming Investor Conferences - Business Wire
- 14 days ago - Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Business Wire
- 4 weeks ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 5 weeks ago - Definium Therapeutics Appoints Roger Adsett to Board of Directors - Business Wire
- 6 weeks ago - Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care - Business Wire
- 7 weeks ago - Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha